![Peoples Health - Your Medicare Advantage Health Team](https://peopleshealth.com/2022-searches/assets/images/PH-logo-380px@72.png)
Phone: 504-849-4500, 225-346-6380, 1-800-631-8443
Fax: 504-849-6901
CORLANOR TAB 5MG
Prior Authorization only applies to members new to therapy?
No
Indications:
All Part D medically-accepted Indications (FDA-approved and compendia-supported).
Exclusion Criteria:
Required Medical Information:
Chronic heart failure (CHF) (initial): Diagnosis of CHF. Patient has NYHA Class II, III, or IV symptoms. Patient has a left ventricular ejection fraction less than or equal to 35%. Patient is in sinus rhythm. Patient has a resting heart rate of greater than or equal to 70 beats per minute. Patient has been hospitalized for worsening HF in the previous 12 months. Trial and failure, contraindication, or intolerance to two of the following at a maximally tolerated dose: A) One of the following: 1) ACE inhibitor (e.g., captopril, enalapril, lisinopril), 2) ARB (e.g., candesartan, losartan, valsartan), or 3) ARNI (e.g., Entresto [sacubitril and valsartan)], B) One of the following: 1) bisoprolol, 2) carvedilol, or 3) metoprolol succinate extended release, C) Sodium-glucose co-transporter 2 (SGLT2) inhibitor [e.g., Jardiance (empagliflozin), Farxiga (dapagliflozin), Xigduo XR (dapagliflozin and metformin)], or D) Mineralocorticoid receptor antagonist (MRA) [e.g., eplerenone, spironolactone]. Dilated Cardiomyopathy (DCM) (initial): Diagnosis of heart failure due to DCM. Patient has NYHA Class II, III, or, IV symptoms. Patient is in sinus rhythm. Patient has an elevated heart rate. Trial and failure, contraindication or intolerance to one of the following: 1) Beta blocker (e.g., bisoprolol, metoprolol succinate extended release), 2) Angiotensin-converting enzyme (ACE) inhibitor (e.g., captopril, enalapril), or 3) Diuretic Agent (e.g., spironolactone, furosemide).
Age Restrictions:
Prescriber Restrictions:
Coverage Duration:
CHF, DCM (Initial, reauth): plan year
Other Criteria:
CHF, DCM (reauth): Documentation of positive clinical response to therapy.
If you are a provider, you can submit a prior authorization request online at https://professionals.optumrx.com.
Updated: 09/2022
Last updated 09/13/2022